Revolade (Northern Ireland) Uses, Dosage, Side Effects and more
| Trade Name | Revolade (Northern Ireland) |
| Generic | ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid |
| Type | Oral Suspension |
| Formula | C18H13N3O4 |
| Weight | Average: 335.3135 Monoisotopic: 335.090605919 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | Novartis Pharmaceuticals UK Ltd |
| Available Country | United Kingdom |
| Last Updated: | January 7, 2025 at 1:49 am |
